|
1
|
Kim M, Suh DH, Yang EJ, Lim MC, Choi JY,
Kim K, No JH and Kim YB: Identifying risk factors for occult lower
extremity lymphedema using computed tomography in patients
undergoing lymphadenectomy for gynecologic cancers. Gynecol Oncol.
144:153–158. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Filip-Ciubotaru F, Manciuc C, Stoleriu G
and Foia L: NADPH Oxidase: Structure and activation mecanisms
(Review). Note I. Rev Med Chir Soc Med Nat Iasi. 120:29–33.
2016.PubMed/NCBI
|
|
3
|
Ciobotaru OR, Lupu MN, Rebegea L,
Ciobotaru OC, Duca OM, Tatu AL, Voinescu CD, Stoleriu G, Earar K
and Miulescu M: Dexamethasone-chemical structure and mechanisms of
action in prophylaxis of postoperative side effects. Rev Chim
(Bucharest). 70:843–847. 2019.(In Romanian).
|
|
4
|
Tatu AL, Ciobotaru OR, Miulescu M, Buzia
OD, Elisei AM, Mardare N, Diaconu C, Robu S and Nwabudike LC:
Hydrochlorothiazide: Chemical structure, therapeutic, phototoxic
and carcinogenetic effects in dermatology. Rev Chim (Bucharest).
69:2110–2114. 2018.(In Romanian).
|
|
5
|
Nwabudike LC and Tatu AL: Response to -
chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e159)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Brănişteanu DE, Pintilie A, Andreş LE,
Dimitriu A, Oanţă A, Stoleriu G and Brănişteanu DC: Ethiopatogenic
hypotheses in lichen planus. Rev Med Chir Soc Med Nat Iasi.
120:760–767. 2016.PubMed/NCBI
|
|
7
|
Ciobotaru OR, Voinescu DC, Ciobotaru OC,
Voicu D and Arbune M: Expression of p53 and Ki-67 in distal
oesophageal and gastric cardia adenocarcinomas. Rom Biotechnol
Lett. 20:10800–10808. 2015.
|
|
8
|
Voinescu DC, Ciobotaru OR, Ciobotaru OC,
Preda A, Lupu VV, Coman MB and Arbune M: Ultrastructural changes of
the gastric mucosa induced by the Helicobacter pylori
infection. Rev Chim. 66:2104–2108. 2015.
|
|
9
|
Schaas BA, Ivan S, Titianu M, Condratovici
CP, Maier A and Schaas CM: Biochemical markers predicting the risk
of gestational diabetes mellitus. Mater Plast. 54:133–136.
2017.
|
|
10
|
Biglia N, Librino A, Ottino MC, Panuccio
E, Daniele A and Chahin A: Lower limb lymphedema and neurological
complications after lymphadenectomy for gynecological cancer. Int J
Gynecol Cancer. 25:521–525. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ki EY, Park JS, Lee KH and Hur SY:
Incidence and risk factors of lower extremity lymphedema after
gynecologic surgery in ovarian cancer. Int J Gynecol Cancer.
26:1327–1332. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rebegea L, Firescu D, Dumitru M and Anghel
R: The incidence and risk factors for occurrence of arm lymphedema
after treatment of breast cancer. Chirurgia (Bucur). 110:33–37.
2015.PubMed/NCBI
|
|
13
|
Kim JH, Choi JH, Ki EY, Lee SJ, Yoon JH,
Lee KH, Park TC, Park JS, Bae SN and Hur SY: Incidence and risk
factors of lower-extremity lymphedema after radical surgery with or
without adjuvant radiotherapy in patients with FIGO stage I to
stage IIA cervical cancer. Int J Gynecol Cancer. 22:686–691.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tada H, Teramukai S, Fukushima M and
Sasaki H: Risk factors for lower limb lymphedema after lymph node
dissection in patients with ovarian and uterine carcinoma. BMC
Cancer. 9(47)2009.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Logmans A, Kruyt RH, de Bruin HG, Cox PH,
Pillay M and Trimbos JB: Lymphedema and lymphocysts following
lymphadenectomy may be prevented by omentoplasty: A pilot study.
Gynecol Oncol. 75:323–327. 1999.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ilancheran A and Monaghan JM: Pelvic
lymphocyst; A 10-year experience. Gynecol Oncol. 29:333–336.
1988.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Smith JW and Conway H: Selection of
appropriate surgical procedures in lymphedema. Introduction of the
hinged pedicle. Plast Reconstr Surg Transplant Bull. 30:10–31.
1962.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Abu-Rustum NR, Alektiar K, Iasonos A, Lev
G, Sonoda Y, Aghajanian C, Chi DS and Barakat RR: The incidence of
symptomatic lower extremity lymphedema following treatment of
uterine corpus malignancies: A 12-year experience at Memorial
Sloan-Kettering Cancer Center. Gynecol Oncol. 103:714–718.
2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kuroda K, Yamamoto Y, Yanagisawa M, Kawata
A, Akiba N, Suzuki K and Naritaka K: Risk factors and a prediction
model for lower limb lymphedema following lymphadenectomy in
gynecologic cancer: A hospital-based retrospective cohort study.
BMC Womens Health. 17(50)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ohba Y, Todo Y, Kobayashi N, Kaneuchi M,
Watari H, Takeda M, Sudo S, Kudo M, Kato H and Sakuragi N: Risk
factors for lower-limb lymphedema after surgery for cervical
cancer. Int J Clin Oncol. 16:238–243. 2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Füller J, Guderian D, Köhler C, Schneider
A and Wendt TG: Lymph edema of the lower extremities after
lymphadenectomy and radiotherapy for cervical cancer. Strahlenther
Onkol. 184:206–211. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mirandola D, Muraca MG, Sgambati E,
Manetti M and Marini M: Role of a structured physical activity
pathway in improving functional disability, pain and quality of
life in a case of breast and gynecological cancer survivorship. J
Clin Med. 8(531)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rebegea L, Firescu D, Baciu G and Ciubara
A: Psycho-oncology support. Brain (Bacau). 10:77–88. 2019.
|
